Cargando…

Glioblastoma-on-a-chip construction and therapeutic applications

Glioblastoma (GBM) is the most malignant type of primary intracranial tumor with a median overall survival of only 14 months, a very poor prognosis and a recurrence rate of 90%. It is difficult to reflect the complex structure and function of the GBM microenvironment in vivo using traditional in vit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Zuorun, Chen, Maosong, Lian, Jiangfang, Wang, Hongcai, Ma, Jingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368971/
https://www.ncbi.nlm.nih.gov/pubmed/37503321
http://dx.doi.org/10.3389/fonc.2023.1183059